2015
DOI: 10.1016/j.jff.2015.02.006
|View full text |Cite
|
Sign up to set email alerts
|

Effects of sulforaphane and its S- and R-enantiomers on the expression and activities of human drug-metabolizing cytochromes P450

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(10 citation statements)
references
References 38 publications
0
8
0
Order By: Relevance
“…In primary rat hepatocytes, SFN significantly inhibited CYP1A1/2, CYP3A and CYP2B activities after 24-h treatment [ 6 , 14 ]. In human hepatocytes, SFN caused a marked decrease in CYP2A6, CYP2C9, CYP2D6, and CYP3A4 activity, but the protein expression of these forms remained unchanged, which indicates that the SFN-caused decrease in CYP activity was not due to the down-regulation of CYP protein [ 15 ]. Ten-day oral treatment with SFN (3 mg/kg or 12 mg/kg) caused a significant decrease in rat liver CYP1A2, CYP2B, and CYP3A4 activity, while the protein expression of CYP1A1/2 was markedly elevated and that of CYP2B and CYP3A2 was decreased [ 16 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In primary rat hepatocytes, SFN significantly inhibited CYP1A1/2, CYP3A and CYP2B activities after 24-h treatment [ 6 , 14 ]. In human hepatocytes, SFN caused a marked decrease in CYP2A6, CYP2C9, CYP2D6, and CYP3A4 activity, but the protein expression of these forms remained unchanged, which indicates that the SFN-caused decrease in CYP activity was not due to the down-regulation of CYP protein [ 15 ]. Ten-day oral treatment with SFN (3 mg/kg or 12 mg/kg) caused a significant decrease in rat liver CYP1A2, CYP2B, and CYP3A4 activity, while the protein expression of CYP1A1/2 was markedly elevated and that of CYP2B and CYP3A2 was decreased [ 16 ].…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, no changes in the mRNA transcript levels of Cyp1a1 and Cyp1a2 were found in SFN-treated rat hepatocytes [ 6 ]. In primary human hepatocytes treated with SFN 10 μM, no induction in the mRNA expression of Cyp1a1 , Cyp1a2 , Cyp2b6 , Cyp2c9 and Cyp3a4 after 24-h treatment was observed [ 15 ], while a great decrease in Cyp3a4 mRNA after 48-h treatment was reported [ 18 ]. In our experiments, the treatment of rat hepatocytes with BNF led to Cyp1a1 , Cyp1a2 , and Cyp3a mRNA induction, which was diminished by SFN co-administration ( Figure 1 ).…”
Section: Discussionmentioning
confidence: 99%
“…In subsequent extended studies, when rat hepatocytes were exposed to various isothiocyanates (20–40 μ m ) a differential effect was seen in that activity was impaired by SFN but induced by PEITC and BITC whereas allyl isothiocyanate had no effect, highlighting the importance of the side chain . In human hepatocytes, both sulforaphane enantiomers impaired CYP2D6 and CYP3A4 activities but at high, nonphysiological concentrations (50–400 μ m ) …”
Section: Modulation Of the Bioactivation Of Chemical Carcinogens By Dmentioning
confidence: 96%
“…23 A previous publication focused on the differences in the degree of interaction between single studies and cocktail studies and proved that the cocktail approach was an adequate and quantitative evaluation method for drug–drug interactions. 24 In addition, it has been deemed that hepatocytes are the most physiologically relevant in vitro system because they contain complete machinery for drug transport and metabolism. 25 Moreover, hepatocyte systems were reported to be more suitable for measuring the activity of UGTs or the expression of both CYPs and UGTs than human liver microsome in vitro systems.…”
Section: Introductionmentioning
confidence: 99%